Press Releases

Tasso Secures $17 Million Series A Financing to Scale Production of At-Home Blood Collection Systems and Capitalize on Growing Demand for Remote Diagnostic Testing

Tasso Inc. completes an oversubscribed $17 million Series A financing round to scale production of at-home blood collection systems

Prospective Study Finds Potential Utility of MeMed's Host Immune Technology for Personalizing Treatment of Severe COVID-19 Patients

Rapid and Continuous Measurement of the Host-Immune Response with MeMed Key™ May Help Clinicians Predict COVID19 Disease Severity, Monitor Inflammatory Status and Guide Treatment Decisions

ndd’s new inline filters offer additional protection against COVID-19 during lung function tests

Andover, MA – 21 July 2020. ndd Medical Technologies (ndd), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung diseases, has introduced new single patient-use, inline filters for its lung function testing devices, in response to the global COVID-19 pandemic. Ensuring an added level of safety, the new filters can be used with ndd’s revolutionary, and highly portable EasyOne® spirometry range, including the EasyOne Air, EasyOne Pro, and EasyOne Pro LAB. EasyOne spirometers are popular among pulmonologists and medical researchers as they are of the most sensitive devices available, delivering reliable, real-time lung function results and diagnosis of chronic lung diseases, even at the point of care.

Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd

Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd (SB3000 Ltd), a pioneer in green, continuous manufacturing of pharmaceutical products.

BioIVT Supports COVID-19 Drug, Diagnostic and Vaccine Researchers by Expanding its Inventory of Patient Plasma, Serum and Saliva Specimens

Specimens can be used to validate SARS-CoV-2 in-vitro diagnostics, develop new drugs and vaccines, and investigate the impact of co-morbidities and social demographics on disease progression

Wearable, Wireless Biometric Sensor Devices from Shimmer Provide Much-Needed Patient Data in Battle Against COVID-19

Bio-Gate signs cooperation agreement with Aesculap AG for coating revision implants

Accumen Launches National Health System Crisis Readiness Survey to Provide Benchmarks and Insights to U.S. Hospitals

Survey will gather data from hospital laboratory, blood management, imaging, and data departments across the nation 

CD Genomics Upgrades Highly Accurate Single-Cell Sequencing Services for Researchers

Creative Enzymes Launches Enzymes for Coronavirus Nucleic Acid Test to Help the Detection of COVID-19

Creative Proteomics Launches Several Newly-developed Services for Protein Related Projects

Broad-spectrum Antiviral Drug Discovery Services Are Ready to Facilitate SARS-CoV-2 Research

Creative Biolabs has combined with integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in SARS-CoV-2 candidates screening, effective viral inhibitors discovery, therapeutic antibody development and vaccine exploration.

Absolute Antibody and University of Zurich Collaborate to Offer Synthetic Nanobodies Against SARS-CoV-2 Receptor Binding Domain

Creative Bioarray Unveils Comprehensive Histology Services to Accelerate the Projects in Biolinical Research

Creative Biogene CRISPR: Offering Solutions for Gene Research with Various Genome Editing Services

CD Genomics Releases Kits and Reagents for Coronavirus Research to Aid in COVID-19 Response

Creative BioMart Enlarged Its Metabolism Proteins List

Profacgen Provides Pharmacophore Modeling for Drug Design

Creative Biostructure Updated Its Membrane Protein Service

Lifeasible Updated Its Physical Purity Testing Service for Seed Testing